Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mathé

Showing results (481-490 of 550) with videos related to

Pageof 55
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
La Nouvelle Presse Medicale|June 19, 1976
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial]P Pouillart, G Mathé, M Poisson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinumG Mathé, Y Kidani, M Segiguchi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 1982
[Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+]J L Misset, G Mathé, J Gastiaburu, et al.
Lancet (London, England)|May 22, 1976
Letter: Remission induction in acute lymphoid and acute myeloid leukaemiasG Mathé, P Pouillart, F De Vassal, et al.
Bulletin Du Cancer|July 1, 1974
[10 years of immunotherapy for acute lymphocytic leukemias. Non-cytologic prognosis factors in acute lymphocytic leukemias]G Mathé, J L Amiel, L Schwarzenberg, et al.
La Nouvelle Presse Medicale|March 3, 1973
[Trials of active immunotherapy in acute lymphocytic leukemia. Influence of different factors on results. Study of 100 cases]G Mathé, P Pouillart, L Schwarzenberg, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|June 1, 1970
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results)G Mathé, J L Amiel, L Schwarzenberg, et al.
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual diseaseG Mathé, R Weiner, P Pouillart, et al.
Pageof 55

Showing results (481-490 of 550) with videos related to

Sort By:
Pageof 55
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
La Nouvelle Presse Medicale|June 19, 1976
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial]P Pouillart, G Mathé, M Poisson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinumG Mathé, Y Kidani, M Segiguchi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Vindesine: a new vinca alkaloidM Bayssas, J Gouveia, F de Vassal, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 1982
[Treatment of leukemias and lymphomas by interferons: II. Phase II of the trial treatment of chronic lymphoid leukemia by human interferon alpha+]J L Misset, G Mathé, J Gastiaburu, et al.
Lancet (London, England)|May 22, 1976
Letter: Remission induction in acute lymphoid and acute myeloid leukaemiasG Mathé, P Pouillart, F De Vassal, et al.
Bulletin Du Cancer|July 1, 1974
[10 years of immunotherapy for acute lymphocytic leukemias. Non-cytologic prognosis factors in acute lymphocytic leukemias]G Mathé, J L Amiel, L Schwarzenberg, et al.
La Nouvelle Presse Medicale|March 3, 1973
[Trials of active immunotherapy in acute lymphocytic leukemia. Influence of different factors on results. Study of 100 cases]G Mathé, P Pouillart, L Schwarzenberg, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|June 1, 1970
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results)G Mathé, J L Amiel, L Schwarzenberg, et al.
National Cancer Institute Monograph|December 1, 1973
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual diseaseG Mathé, R Weiner, P Pouillart, et al.
Pageof 55